Anzeige
+++InnoCan Pharma: Hat dieses Unternehmen die Lösung aller CBD-Probleme für Merck & Co?+++
Kiromic Biopharma ISIN: US4976341051
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
Anzeige
![Smartbroker]()
Alles ab 0 Euro pro Order. Dauerhaft.
Summer.76,
13. Mai 15:31
https://www.businesswire.com/news/home/20220513005108/en/Kiromic-BioPharma-Reports-First-Quarter-2022-Financial-Results-and-Recent-Corporate-Highlights
DeRitter,
12. Mai 22:24
👀
Mr.Krabs,
12. Mai 19:14
Pleite
Summer.76,
11. Mai 14:39
https://finance.yahoo.com/news/kiromic-biopharma-announces-company-directly-105800477.html
Summer.76,
5. Mai 17:44
Volumen, aber keine News (bisher)
senveben,
5. Mai 17:36
🧐
Summer.76,
9. Apr 8:03
Kiromic BioPharma Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Highlights
https://www.businesswire.com/news/home/20220408005450/en/Kiromic-BioPharma-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-Recent-Corporate-Highlights
Kiromic BioPharma GAAP EPS of -$2.26
https://seekingalpha.com/news/3822118-kiromic-biopharma-gaap-eps-of-2_26
Kiromic BioPharma press release (NASDAQ:KRBP): FY GAAP EPS of -$2.26.
Cash and equivalents were $25.35M as of December 31, 2021, compared to $10.15M as of December 31, 2020.
Summer.76,
11. Mär 22:47
Kiromic BioPharma GAAP EPS of -$0.40 misses by $0.14
https://seekingalpha.com/news/3812856-kiromic-biopharma-gaap-eps-of-0_40-misses-0_14
Kiromic BioPharma press release (NASDAQ:KRBP): Q3 GAAP EPS of -$0.40 misses by $0.14.
Cash and cash equivalents were $36.16M as of September 30, 2021, compared to $10.15M as of December 31, 2020.
|
|
Kommentare | ||
|---|---|---|---|
| 1 | Kiromic BioPharma |
Kursdetails
| Geld (bid) | 0,260 (0) |
|---|---|
| Brief (ask/offer) | 0,282 (0) |
| Spread | 7,801 |
| Geh. Stück | 0 |
| Eröffnung | 0,297 |
| Vortag | 0,294 |
| Tageshoch | 0,299 |
| Tagestief | 0,270 |
| 52W Hoch | 2,760 |
| 52W Tief | 0,278 |
Tagesvolumen
| in EUR gehandelt | 0 Stk |
|---|---|
| in USD gehandelt | 9.107 Stk |
| Gesamt | 9.107 Stk |
Anzeige
![Smartbroker]()
Der Broker von Deutschlands größter Finanzcommunity
Geld/Brief Kurse
| Börse | Geld | Brief | Zeit | Volumen | Kurs |
|---|---|---|---|---|---|
| Frankfurt | 0,290 | 0,330 | 1653287819 08:36 | 0,268 EUR | |
| München | 0,276 | 0,298 | 1653285649 08:00 | 0,320 EUR | |
| Stuttgart | 0,284 | 0,302 | 1653286455 08:14 | 0,268 EUR | |
| Nasdaq | 0,291 | 0,307 | 1653312838 15:33 | 9.007 Stk | 0,305 USD |
| AMEX | 1653091200 21. May | 100 Stk | 0,306 USD | ||
| Tradegate | 0,268 | 0,272 | 1653078439 20. May | 0,292 EUR | |
| London | 1651762898 5. May | 0,718 USD | |||
| Gettex | 0,260 | 0,282 | 1653313381 15:43 | 0,282 EUR | |
| Baader Bank | 0,260 | 0,282 | 1653313873 15:51 | 0,271 EUR | ges. 9.107 Stk |
Realtime / Verzögert
Börsennotierung
| Marktkapitalisierung in EUR |
|---|
| 4,6 Mio. |
| Anzahl der Aktien |
| 15,8 Mio. |
Grundlegende Daten zur Kiromic Biopharma Aktie
| Finanzdaten | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e |
|---|---|---|---|---|---|---|---|
| KUV | - | - | - | - | - | - | - |
| Ergebnis je Aktie (bereinigt) | - | - | - | - | - | - | - |
| Cashflow | - | - | - | - | - | - | - |
| Eigenkapitalquote | - | - | - | - | - | - | - |
| Verschuldungsgrad | - | - | - | - | - | - | - |
| Eigenkapitalrendite | - | - | - | - | - | - | - |
| Gesamtkapitalrendite | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - |
| Fundamentaldaten | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e |
| KCV | - | - | - | - | - | - | - |
| Dividendenrendite | - | - | - | - | - | - | - |
| Kurs-Gewinn-Verhältnis (KGV) | - | - | - | - | - | - | - |
| Dividende je Aktie | - | - | - | - | - | - | - |
| Bilanzdaten | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e |
| Netto-Provisionsüberschuss | - | - | - | - | - | - | - |
| Umsatzerlöse | - | - | - | - | - | - | - |
| Ergebnis vor Steuern | - | - | - | - | - | - | - |
| Steuern | - | - | - | - | - | - | - |
| Ausschüttungssumme | - | - | - | - | - | - | - |
| Nettoverzinsung | - | - | - | - | - | - | - |
| Zinsertrag | - | - | - | - | - | - | - |
| Gesamtertrag | - | - | - | - | - | - | - |